By ipomarket.in Editorial Team · Last reviewed: 2026-10-31
Disclaimer: This article is for informational purposes only and does not constitute investment advice. IPO investments are subject to market risks. Please read the offer document carefully and consult a SEBI-registered investment advisor before investing.
Every IPO season, the same two numbers dominate WhatsApp groups and YouTube thumbnails: the grey market premium (GMP) and the subscription figure. Both are easy to quote, both feel like verdicts, and both tell you almost nothing about whether a business will earn its valuation over the next few years. This article walks through why fundamental metrics — return on equity (ROE), return on capital employed (ROCE) and cash flow — are more reliable indicators of IPO quality than GMP and hype.
What GMP actually measures
Grey market premium is the unofficial price difference between an IPO's issue price and the price at which its shares change hands in the grey market before they list on the exchange. Market participants in India use it as an informal read on investor sentiment and possible listing performance. But it is not regulated by SEBI, NSE or BSE.
That unregulated nature matters. GMP reflects emotions and sentiment, not fundamentals. It can jump simply because of hype around a company, which is why it is better thought of as a temperature check than a quality indicator. It does not reflect company fundamentals, valuation, or how the business is likely to perform over the next few years.
There is also a practical risk baked into the grey market itself. Grey market transactions carry significant counterparty risk — there is no exchange, no clearing house, and no legal mechanism to enforce grey market agreements in India. If you want the full mechanics, our guide to IPO GMP covers how the figure is quoted and traded.
GMP and oversubscription are not quality
A strong GMP or heavy oversubscription does not guarantee a quality IPO. Subscription multiples tell you how many people wanted shares — not whether the business earns its valuation. A company with a high GMP can still be overvalued, while a company with a low GMP can still be fundamentally strong.
The predictive record is also weaker than the hype suggests. According to one analysis, GMP has roughly a 60-70 percent correlation with the actual listing price, not 100 percent, which makes it an imperfect signal even for the one thing it is supposed to predict. Separately, it has been reported that when GMP ran at 20-30 percent or higher, IPOs often listed strong, but when GMP sat below 5 percent the outcomes were mixed and the low reading did not predict anything clearly.
So GMP, at best, is a sentiment gauge for listing day. It says nothing about the three-to-five-year question that actually decides whether you make money.
ROE: how efficiently the company uses your money
Return on equity measures profit divided by average shareholders' equity. In plain terms, it tells you how much profit the business generates for every rupee of owners' capital. Strong Indian companies show ROE of 15-25 percent consistently.
The word to focus on is consistently. A single good year can be an accident of a one-off gain or an accounting quirk. A company that compounds equity at a healthy rate year after year is demonstrating something GMP can never show: that the underlying business is genuinely productive.
One caution with ROE: it can be flattered by debt. A company that borrows heavily can show a high ROE even if the operating business is mediocre, because the equity base is small relative to the capital actually employed. That is exactly why the next metric matters.
ROCE: the leverage-proof check
Return on capital employed is less sensitive to leverage than ROE because it includes both equity and debt in the capital employed. That makes it a cleaner read on how well a company uses its total funding, not just the shareholders' slice.
As a rough frame for Indian IPOs: ROCE of 20 percent or higher is considered strong, while 15-20 percent is average. ROCE below 12 percent generally suggests a capital-intensive business with limited pricing power. More broadly, a ROCE of 15 or higher is generally considered a good ratio in the Indian stock markets, according to published analysis.
Reading ROE and ROCE together is the useful trick. If ROE is high but ROCE is modest, debt is doing the heavy lifting. If both are strong and stable, the business is likely earning real returns on the capital it deploys — the kind of quality GMP simply cannot price in.
Cash flow: the hardest number to fake
Profit on a profit-and-loss statement is an accounting figure. Cash flow is money that actually moved. A business can report rising profits while operating cash flow stays weak or negative, which is often a warning that reported earnings are not converting into cash.
That is why cash flow belongs in any serious IPO check alongside the revenue trend, debt-to-equity ratio and margins. Before applying to any IPO, the sensible sequence is to spend time on the red herring prospectus (RHP) analysing these items, and to treat GMP and subscription numbers as sentiment indicators rather than substitutes for that work. Our RHP financials guide breaks down exactly where to find these line items in the document.
A fundamentals-first framework
Putting it together, the inputs that matter more than GMP for IPO analysis are business quality, valuation, the financial trend, peer comparison, subscription quality and market context. A practical order of work looks like this:
- Business quality — read the RHP, understand how the company makes money and whether that is durable.
- ROE and ROCE — check the levels against the 15-25 percent (ROE) and 20 percent-plus (ROCE) benchmarks, and check consistency across years.
- Cash flow — confirm that profits are backed by operating cash.
- Valuation and peers — compare the asking price to listed peers on the same metrics.
- Sentiment last — only then glance at GMP and subscription as a temperature check, never as the decision.
For a deeper look at how grey market signals and business quality diverge, see our note on what GMP really tells you versus business quality.
None of this guarantees a profitable IPO. But it shifts your decision from a sentiment number you cannot verify to figures that are published, auditable, and tied to the actual economics of the business.
FAQ
Is a high GMP a reliable sign that an IPO is worth applying to?
No. A strong GMP or oversubscription does not guarantee a quality IPO. GMP reflects sentiment and can rise on hype alone; it does not capture fundamentals or valuation. A high-GMP company can be overvalued, and a low-GMP company can be fundamentally strong.
What ROE and ROCE levels are considered healthy for Indian companies?
Strong Indian companies show ROE of 15-25 percent consistently. For ROCE, 20 percent or higher is considered strong and 15-20 percent is average, while below 12 percent suggests a capital-intensive business with limited pricing power. A ROCE of 15 or higher is generally viewed as good in Indian markets.
Why look at ROCE if ROE is already high?
ROE can be inflated by debt because it only counts equity. ROCE is less sensitive to leverage since it includes both equity and debt in capital employed. Reading them together shows whether high returns are genuine or borrowed.
How accurate is GMP as a predictor of listing price?
It is imperfect. One analysis puts GMP's correlation with the actual listing price at roughly 60-70 percent, not 100 percent. Reportedly, GMP above 20-30 percent often coincided with strong listings, but readings below 5 percent produced mixed outcomes.
Is trading in the grey market safe?
Grey market transactions carry significant counterparty risk. There is no exchange, clearing house or legal mechanism to enforce grey market agreements in India, and GMP itself is not regulated by SEBI, NSE or BSE.
Last reviewed: 2026-10-31 by the ipomarket.in Editorial Team.